Identification and characterization of a novel monoamine transporter in the human brain.
about
Adenosine transporter ENT4 is a direct target of EWS/WT1 translocation product and is highly expressed in desmoplastic small round cell tumorMembrane potential and pH-dependent accumulation of decynium-22 (1,1'-diethyl-2,2'-cyanine iodide) flourencence through OCT transporters in astrocytesDecynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depressionMolecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 familyMembrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cellsExpression profiling of the solute carrier gene family in the mouse brainUnfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacyEvidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brainMembrane-Bound Catechol-O-Methyl Transferase in Cortical Neurons and Glial Cells is Intracellularly OrientedTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?Metformin and the gastrointestinal tractBlood brain barrier: a challenge for effectual therapy of brain tumorsEquilibrative nucleoside transporters-A review.Quinine enhances the behavioral stimulant effect of cocaine in mice.Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake.Label-free dopamine imaging in live rat brain slices.Glucagon effects on 3H-histamine uptake by the isolated guinea-pig heart during anaphylaxis.Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cationsSelective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3Tyrosine 112 is essential for organic cation transport by the plasma membrane monoamine transporterGene-sex interactions in schizophrenia: focus on dopamine neurotransmission.Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.Expression and immunolocalization of the plasma membrane monoamine transporter in the brainMotoneuron excitability and muscle spasms are regulated by 5-HT2B and 5-HT2C receptor activity.Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gunPodocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injuryPodocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity.Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.Nonexocytotic serotonin release tonically suppresses serotonergic neuron activity.Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers.Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene.Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).Molecular analysis and structure-activity relationship modeling of the substrate/inhibitor interaction site of plasma membrane monoamine transporter.Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy.Functional Analysis of Novel Candidate Regulators of Insulin Secretion in the MIN6 Mouse Pancreatic β Cell LineElectrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter.Residue Ile89 in human plasma membrane monoamine transporter influences its organic cation transport activity and sensitivity to inhibition by dilazepAn immunohistochemical analysis of SERT in the blood-brain barrier of the male rat brain
P2860
Q21092207-BD90D1E5-4884-4F6E-9CF9-338A2492368BQ24595515-4AA54790-BE4D-440C-8B3C-A8E548E29799Q24611123-8E3D8B11-69D0-46ED-92E9-0104E5007AE2Q24655176-1C1E8C91-8A0C-475D-BF47-000284245DDAQ24655213-705D4E6F-0B24-4A61-90CD-164DB8B85BD0Q24655257-8B34B6FB-A71A-4363-9F4C-1D7836BF3D9EQ24658095-6B22A4DF-3D0A-47F5-8004-6759648377A3Q24678282-459B5D6A-E7C6-4A02-8FA2-51E93383102EQ27500447-DEE0BCF0-EDC2-4416-AD96-43C85C71353BQ27690256-16180F70-8566-4872-A53A-2CDBC9AF932DQ28078271-8641D901-16E6-4426-9DF2-E6F1D9E4CEDAQ28079250-3D7450B5-E1B8-48C2-9492-9A4D4D2B01A3Q28081947-B51F702E-8E9B-4363-8EC4-80BBA810E6CAQ30244329-7ED0547E-44EA-4E97-8C5A-1FABC961DBBFQ30392526-CDD5203D-320C-4DDB-8FEF-E3817A88E899Q30571118-9A0299A0-CF66-4A1E-A317-6F475410B649Q33584577-986B31E7-202A-42B9-A5FA-941EA81C230AQ33649373-42C3F85E-1AFD-4F3F-9F4E-215FCD8AFCDBQ33667252-A5B6B118-926E-467C-9F20-71F5F69AD4F7Q34211096-8E81FF79-E84A-4617-81A6-B40129C9D807Q34359911-BAB8FEA4-AAEF-4CFF-8C0B-D8807E1FC4BAQ34367791-2A9C1EF3-1E9B-42AE-B437-02B442456DC6Q34410670-A51377F3-51C0-49F7-94D7-C794EE9C29E2Q34540567-25ACA1A6-88CD-4DEF-B74D-D9144718A78FQ34615851-C67FB251-1312-4F92-8755-15B586934DD2Q34686451-5225222C-3F81-411D-891C-3A7A47E70661Q34721872-0FA34C44-1A91-4D23-BE03-2084E5B33A57Q34805111-FD6AE61F-7C7C-480B-94AD-951409351DC1Q34974839-EF4A2F93-6FC5-4476-9DA7-5B02DA4AFCC3Q35090255-38A6E9D6-EA4E-48CE-B3B5-9D32CD4114BCQ35112953-31435EC4-0DF4-454F-BE12-3E8491E2583EQ35156413-FC1C185F-C478-4773-AC97-7E3284C257C8Q35208018-21DBA85F-23DC-44D0-8B3C-4F49A5B81261Q35213302-17982337-7C55-4DB5-8DE3-00E8B318FAC3Q35429797-C670A2B6-5492-4104-816A-0B6FCF7A83CFQ35579449-D3D61093-2301-487C-8CF1-B4C6EF6A708EQ35961147-48077958-61FB-4C7F-85EC-C6118887C38DQ35996455-383F5780-DE52-4248-A295-D1F835E825B0Q36024314-0D461964-FBDD-42D9-B4FF-A0303115D5B9Q36075219-67405EFB-1139-4B09-A283-374E1865023F
P2860
Identification and characterization of a novel monoamine transporter in the human brain.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Identification and characterization of a novel monoamine transporter in the human brain.
@ast
Identification and characterization of a novel monoamine transporter in the human brain.
@en
Identification and characterization of a novel monoamine transporter in the human brain.
@nl
type
label
Identification and characterization of a novel monoamine transporter in the human brain.
@ast
Identification and characterization of a novel monoamine transporter in the human brain.
@en
Identification and characterization of a novel monoamine transporter in the human brain.
@nl
prefLabel
Identification and characterization of a novel monoamine transporter in the human brain.
@ast
Identification and characterization of a novel monoamine transporter in the human brain.
@en
Identification and characterization of a novel monoamine transporter in the human brain.
@nl
P2093
P2860
P356
P1476
Identification and characterization of a novel monoamine transporter in the human brain.
@en
P2093
Joanne Wang
Karen Engel
Mingyan Zhou
P2860
P304
50042-50049
P356
10.1074/JBC.M407913200
P407
P577
2004-09-23T00:00:00Z